• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

南美洲致幻植物中的单胺氧化酶抑制剂:死藤水的色胺和β-咔啉成分。

Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and beta-carboline constituents of ayahuasca.

作者信息

McKenna D J, Towers G H, Abbott F

出版信息

J Ethnopharmacol. 1984 Apr;10(2):195-223. doi: 10.1016/0378-8741(84)90003-5.

DOI:10.1016/0378-8741(84)90003-5
PMID:6587171
Abstract

Ayahuasca is a hallucinogenic beverage derived by boiling the bark of the Malpighiaceous liana Banisteriopsis caapi together with the leaves of various admixture plants, viz. Psychotria viridis, Psychotria carthagenensis , or Diplopterys cabrerana . B. caapi contains harmine, harmaline, and tetrahydroharmine while the admixtures contain N,N-dimethyltryptamine (DMT). DMT, a potent hallucinogen, is inactive orally due to degradation by visceral monoamine oxidase (MAO). The beta-carbolines, however, are highly active reversible inhibitors of MAO and may protect the DMT from deamination by MAO and render it orally active. This mechanism has been proposed to underlie the oral activity of ayahuasca but has not been experimentally confirmed. In the present study the constituents of the admixture plants and the alkaloids of eight ayahuasca samples from Peru were qualitatively and quantitatively analyzed using two-dimensional thin-layer chromatography (TLC), high pressure liquid chromatography (HPLC) and gas chromatography/mass spectrometry (GC/MS). Several B. caapi cultivars were quantitatively compared for variations in alkaloid content. Three admixture plants used rarely in the manufacture of ayahuasca were also screened for alkaloids. A selected sample of beta-carbolines were screened for activity as MAO inhibitors using an in vitro assay system, and structure/activity relationships were compared. Inhibition observed with single compounds was compared with the activity of selected samples of ayahuasca which were screened in the system and also with the activity of mixtures of beta-carbolines. The levels of DMT and beta-carbolines found in the ayahuasca samples examined in the present study were an order of magnitude greater than the levels reported in a previous study. Ayahuasca was found to be an extremely effective inhibitor of MAO in vitro and the degree of inhibition was directly correlated with the concentration of MAO-inhibiting beta-carbolines. Inhibition experiments using mixtures of beta-carbolines indicated that their effects in combination are additive, rather than synergistic or antagonistic. Implications of the results in understanding the pharmacology of ayahuasca are discussed.

摘要

阿亚瓦斯卡是一种致幻饮料,由马钱科藤本植物卡皮藤(Banisteriopsis caapi)的树皮与各种混合植物的叶子一起煮沸制成,这些混合植物包括绿心叶树(Psychotria viridis)、卡塔赫纳绿心叶树(Psychotria carthagenensis)或卡氏二翅萼(Diplopterys cabrerana)。卡皮藤含有哈尔明、哈尔马灵和四氢哈尔明,而混合植物含有N,N-二甲基色胺(DMT)。DMT是一种强效致幻剂,由于会被内脏单胺氧化酶(MAO)降解,口服时无活性。然而,β-咔啉是MAO的高效可逆抑制剂,可能会保护DMT不被MAO脱氨基并使其口服具有活性。有人提出这种机制是阿亚瓦斯卡口服活性的基础,但尚未得到实验证实。在本研究中,使用二维薄层色谱(TLC)、高压液相色谱(HPLC)和气相色谱/质谱联用(GC/MS)对混合植物的成分以及来自秘鲁的八个阿亚瓦斯卡样品中的生物碱进行了定性和定量分析。对几种卡皮藤品种的生物碱含量变化进行了定量比较。还对三种很少用于制造阿亚瓦斯卡的混合植物进行了生物碱筛选。使用体外检测系统对选定的β-咔啉样品进行了MAO抑制剂活性筛选,并比较了结构/活性关系。将单一化合物的抑制作用与在该系统中筛选的选定阿亚瓦斯卡样品的活性以及β-咔啉混合物的活性进行了比较。本研究中检测的阿亚瓦斯卡样品中发现的DMT和β-咔啉水平比先前研究报告的水平高一个数量级。发现阿亚瓦斯卡在体外是一种极其有效的MAO抑制剂,抑制程度与MAO抑制性β-咔啉的浓度直接相关。使用β-咔啉混合物的抑制实验表明,它们的联合作用是相加的,而不是协同或拮抗的。讨论了这些结果在理解阿亚瓦斯卡药理学方面的意义。

相似文献

1
Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and beta-carboline constituents of ayahuasca.南美洲致幻植物中的单胺氧化酶抑制剂:死藤水的色胺和β-咔啉成分。
J Ethnopharmacol. 1984 Apr;10(2):195-223. doi: 10.1016/0378-8741(84)90003-5.
2
Monoamine oxidase inhibitors in South American hallucinogenic plants Part 2: Constituents of orally-active Myristicaceous hallucinogens.南美致幻植物中的单胺氧化酶抑制剂 第2部分:口服活性肉豆蔻科致幻剂的成分
J Ethnopharmacol. 1984 Nov;12(2):179-211. doi: 10.1016/0378-8741(84)90048-5.
3
Metabolism and disposition of N,N-dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca.口服安非他命和 harmala 生物碱后 N,N-二甲基色胺的代谢和处置。
Drug Test Anal. 2012 Jul-Aug;4(7-8):610-6. doi: 10.1002/dta.1344. Epub 2012 Apr 19.
4
Kinetic profile of N,N-dimethyltryptamine and β-carbolines in saliva and serum after oral administration of ayahuasca in a religious context.口服宗教背景下的阿育吠陀后唾液和血清中 N,N-二甲基色胺和β-咔啉的动力学特征。
Drug Test Anal. 2021 Mar;13(3):664-678. doi: 10.1002/dta.2955. Epub 2020 Nov 3.
5
Identification of N,N-dimethyltryptamine and beta-carbolines in psychotropic ayahuasca beverage.从致幻性死藤水饮料中鉴定出N,N-二甲基色胺和β-咔啉。
Biomed Chromatogr. 2008 Oct;22(10):1056-9. doi: 10.1002/bmc.1023.
6
Gas chromatographic analysis of dimethyltryptamine and beta-carboline alkaloids in ayahuasca, an Amazonian psychoactive plant beverage.对阿亚瓦斯卡(一种亚马逊地区具有精神活性的植物饮料)中二甲色胺和β-咔啉生物碱的气相色谱分析。
Phytochem Anal. 2009 Mar-Apr;20(2):149-53. doi: 10.1002/pca.1110.
7
Investigation of Ayahuasca β-Carboline Alkaloids and Tryptamine in Sweat Samples from Religious Community Participants by GC-MS.GC-MS 法研究宗教社区参与者汗液中的安非他命 β-咔啉生物碱和色胺。
J Anal Toxicol. 2020 Jul 31;44(6):601-609. doi: 10.1093/jat/bkz116.
8
Neurobiological research on N,N-dimethyltryptamine (DMT) and its potentiation by monoamine oxidase (MAO) inhibition: from ayahuasca to synthetic combinations of DMT and MAO inhibitors.神经生物学对 N,N-二甲基色胺(DMT)及其单胺氧化酶(MAO)抑制作用的研究:从雅砻酒到 DMT 和 MAO 抑制剂的合成组合。
Cell Mol Life Sci. 2024 Sep 10;81(1):395. doi: 10.1007/s00018-024-05353-6.
9
Determination of Tryptamines and β-Carbolines in Ayahuasca Beverage Consumed During Brazilian Religious Ceremonies.巴西宗教仪式中饮用的死藤水饮料中色胺和β-咔啉的测定。
J AOAC Int. 2017 May 1;100(3):820-824. doi: 10.5740/jaoacint.16-0337. Epub 2017 Jan 19.
10
Monoamine Oxidase Inhibition by Plant-Derived β-Carbolines; Implications for the Psychopharmacology of Tobacco and Ayahuasca.植物源性β-咔啉对单胺氧化酶的抑制作用;对烟草和死藤水精神药理学的影响。
Front Pharmacol. 2022 May 2;13:886408. doi: 10.3389/fphar.2022.886408. eCollection 2022.

引用本文的文献

1
Psychedelics and the Serotonin Hypothesis of Eating Disorders.迷幻药与饮食失调的血清素假说
Brain Sci. 2025 Aug 21;15(8):893. doi: 10.3390/brainsci15080893.
2
Untargeted metabolomics reveals quinic acid as the kiwifruit component that affects brain activity in mice.非靶向代谢组学揭示奎尼酸是影响小鼠大脑活动的猕猴桃成分。
PLoS One. 2025 Aug 18;20(8):e0326134. doi: 10.1371/journal.pone.0326134. eCollection 2025.
3
Exploring the Therapeutic Effects of Psychedelics Administered to Military Veterans in Naturalistic Retreat Settings.
探索在自然静修环境中给予退伍军人迷幻药的治疗效果。
Brain Behav. 2025 Jul;15(7):e70660. doi: 10.1002/brb3.70660.
4
The Therapeutic Potential of Psychedelics in Treating Substance Use Disorders: A Review of Clinical Trials.迷幻剂在治疗物质使用障碍中的治疗潜力:临床试验综述
Medicina (Kaunas). 2025 Feb 6;61(2):278. doi: 10.3390/medicina61020278.
5
Cardiac effects of two hallucinogenic natural products, N,N-dimethyl-tryptamine and 5-methoxy-N,N-dimethyl-tryptamine.两种致幻天然产物N,N-二甲基色胺和5-甲氧基-N,N-二甲基色胺对心脏的影响。
Sci Rep. 2025 Feb 25;15(1):6715. doi: 10.1038/s41598-025-91400-6.
6
Ayahuasca-assisted meaning reconstruction therapy for grief: a non-randomized clinical trial protocol.用于悲伤治疗的死藤水辅助意义重建疗法:一项非随机临床试验方案。
Front Psychiatry. 2025 Jan 7;15:1484736. doi: 10.3389/fpsyt.2024.1484736. eCollection 2024.
7
Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post-Hoc Analysis.服用裸盖菇素后赛洛新的临床药代动力学:系统评价与事后分析
Clin Pharmacokinet. 2025 Jan;64(1):53-66. doi: 10.1007/s40262-024-01454-4. Epub 2025 Jan 15.
8
Effects of psychedelics on neurogenesis and broader neuroplasticity: a systematic review.迷幻剂对神经发生及更广泛神经可塑性的影响:一项系统综述
Mol Med. 2024 Dec 19;30(1):244. doi: 10.1186/s10020-024-01013-4.
9
Harnessing Pharmacogenomics in Clinical Research on Psychedelic-Assisted Therapy.在迷幻剂辅助治疗的临床研究中应用药物基因组学
Clin Pharmacol Ther. 2025 Jan;117(1):106-115. doi: 10.1002/cpt.3459. Epub 2024 Sep 30.
10
Dysfunction of the NMDA Receptor in the Pathophysiology of Schizophrenia and/or the Pathomechanisms of Treatment-Resistant Schizophrenia.NMDA 受体功能障碍在精神分裂症病理生理学和/或治疗抵抗性精神分裂症发病机制中的作用。
Biomolecules. 2024 Sep 6;14(9):1128. doi: 10.3390/biom14091128.